BRIEF-Vertex Pharmaceuticals says reiterates 2016 guidance By: Reuters: Company News July 27, 2016 at 16:43 PM EDT * Vertex pharmaceuticals inc says reiterates 2016 guidance for orkambi product revenues of $1.0 to $1.1 billion Read More >> Related Stocks: Vertex Pharmaceuticals